Cargando…

Immune response to hepatitis B vaccination in HIV-positive individuals with isolated antibodies against hepatitis B core antigen: Results of a prospective Italian study

BACKGROUND AND AIM: Antibodies against hepatitis B core antigen (anti-HBc) are found in 14–44% of patients with HIV infection, but it is still unclear whether hepatitis B virus (HBV) vaccination should be recommended for HIV-positive subjects with isolated anti-HBc (IAHBc). We examined the rate of a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morsica, Giulia, Bagaglio, Sabrina, Spagnuolo, Vincenzo, Castagna, Antonella, Di Serio, Clelia, Galli, Andrea, Della Torre, Liviana, Andolina, Andrea, Pramov, Alexander, Uberti-Foppa, Caterina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581175/ https://www.ncbi.nlm.nih.gov/pubmed/28863182 http://dx.doi.org/10.1371/journal.pone.0184128

Ejemplares similares

Frequency of Natural Resistance within NS5a Replication Complex Domain in Hepatitis C Genotypes 1a, 1b: Possible Implication of Subtype-Specific Resistance Selection in Multiple Direct Acting Antivirals Drugs Combination Treatment
por: Bagaglio, Sabrina, et al.
Publicado: (2016)

Virological pattern of hepatitis B infection in an HIV-positive man with fatal fulminant hepatitis B: a case report
por: Bagaglio, Sabrina, et al.
Publicado: (2009)

Risk of HIV viral rebound in HIV infected patients on direct acting antivirals (DAAs) treatment for HCV
por: Morsica, Giulia, et al.
Publicado: (2022)

Modelling the impact of protein-kinase R allelic variant on HIV biomarkers trajectories by means of latent class mixed models
por: Brombin, Chiara, et al.
Publicado: (2022)

Dynamic of Mixed HCV Infection in Plasma and PBMC of HIV/HCV Patients Under Treatment With Peg-IFN/Ribavirin
por: Bagaglio, Sabrina, et al.
Publicado: (2015)

Geographic Distribution of HCV-GT3 Subtypes and Naturally Occurring Resistance Associated Substitutions
por: Bagaglio, Sabrina, et al.
Publicado: (2019)

A Prospective Italian Study on Baseline NS3 and NS5A Resistance to Direct-Acting Antivirals in a Real-World Setting of HIV-1/HCV Coinfected Patients and Association with Treatment Outcome
por: Bagaglio, Sabrina, et al.
Publicado: (2020)

Levels of Alpha-Fetoprotein and Association with Mortality in Hepatocellular Carcinoma of HIV-1-Infected Patients
por: Morsica, Giulia, et al.
Publicado: (2022)

Natural polymorphisms in the resistance associated sites of HCV-G1 NS5B domain and correlation with geographic origin of HCV isolates
por: Bagaglio, Sabrina, et al.
Publicado: (2018)

Compartmentalization of Resistance-Associated Substitutions in HIV/HCV-Infected Patients: Possible Correlation with Infecting HCV Genotype
por: Morsica, Giulia, et al.
Publicado: (2021)

Survival in People Living with HIV with or without Recurrence of Hepatocellular Carcinoma after Invasive Therapy
por: Bertoni, Costanza, et al.
Publicado: (2023)

Molecular epidemiology of HIV-1 infection in immigrant population in northern Italy
por: Sagnelli, Caterina, et al.
Publicado: (2020)

Monkeypox in a patient with undifferentiated connective tissue disease
por: Clemente, Tommaso, et al.
Publicado: (2022)

Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patients
por: Sagnelli, Caterina, et al.
Publicado: (2013)

Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co‐infected HIV patients with cirrhosis
por: Willemse, Sophie, et al.
Publicado: (2019)

2408. Is Shorter Antibiotic Treatment Feasible in Patients with Cardiac Implantable Electronic Devices (CIED) Infections? Impact of Treatment Duration on 6-Month Recurrence and Mortality
por: Ponta, Giacomo, et al.
Publicado: (2023)

Socio-demographic determinants of coinfections by HIV, hepatitis B and hepatitis C viruses in central Italian prisoners
por: La Torre, Giuseppe, et al.
Publicado: (2007)

Epidemiological Impact of Mandatory Vaccination against Hepatitis B in Italian Young Adults
por: Campagna, Marcello, et al.
Publicado: (2011)

A Nonparametric Procedure for Defining a New Humoral Immunologic Profile in a Pilot Study on HIV Infected Patients
por: Brombin, Chiara, et al.
Publicado: (2013)

Hepatitis B Core-Related Antigen and New Therapies for Hepatitis B
por: Watanabe, Takehisa, et al.
Publicado: (2021)

Impact of Universal Vaccination Against Hepatitis B: The Italian Model
por: Coppola, Rosa Cristina, et al.
Publicado: (2012)

Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients
por: Gianotti, Nicola, et al.
Publicado: (2017)

Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols
por: Caputo, Valeria, et al.
Publicado: (2020)

Expression of Hepatocyte Hepatitis B Core Antigen and Hepatitis B Surface Antigen as a Marker in the Management of Chronic Hepatitis B Patients
por: Yim, Sun Young, et al.
Publicado: (2017)

Serum hepatitis B core-related antigen as a surrogate marker of hepatitis B e antigen seroconversion in chronic hepatitis B
por: Chi, Xiu-Mei, et al.
Publicado: (2021)

Let It “B”? The Role of Hepatitis B Universal Vaccination among Italian Problematic Drug Users
por: Lugoboni, Fabio, et al.
Publicado: (2015)

An assessment of the effect of hepatitis B vaccine in decreasing the amount of hepatitis B disease in Italy
por: La Torre, Giuseppe, et al.
Publicado: (2008)

Atypical Hepatitis B Virus Serology Profile—Hepatitis B Surface Antigen-Positive/Hepatitis B Core Antibody-Negative—In Hepatitis B Virus/HIV Coinfected Individuals in Botswana
por: Phinius, Bonolo B., et al.
Publicado: (2023)

Hepatitis B Virus Reactivation upon Immunosuppression: Is There a Role for Hepatitis B Core-Related Antigen in Patients with Immune-Escape Mutants? A Case Report
por: Caviglia, Gian Paolo, et al.
Publicado: (2021)

Hepatitis B viremia in completely immunized individuals negative for anti-hepatitis B core antibody
por: Lai, Ming-Wei, et al.
Publicado: (2016)

Conservation and variability of hepatitis B core at different chronic hepatitis stages
por: Yll, Marçal, et al.
Publicado: (2020)

Hepatitis B Vaccination: A Historical Overview with a Focus on the Italian Achievements
por: Romano’, Luisa, et al.
Publicado: (2022)

THE SEROPREVALENCE OF THE HEPATITIS B VIRUS IN ITALIAN MEDICAL STUDENTS AFTER 3 DECADES SINCE THE INTRODUCTION OF UNIVERSAL VACCINATION
por: Sartorelli, Pietro, et al.
Publicado: (2022)

Persistence of Immunity for Hepatitis B Virus among Heathcare Workers and Italian Medical Students 20 Years after Vaccination
por: Coppeta, Luca, et al.
Publicado: (2019)

Hepatitis B vaccination and immunotherapies: an update
por: Stasi, Cristina, et al.
Publicado: (2020)

Molecular Characterization of Pre-Core/Core and S Region of Hepatitis B Virus in Hemodialysis Patients With Occult Hepatitis B Infection
por: Rastegarvand, Nasrin, et al.
Publicado: (2015)

Intracellular hepatitis B virus increases hepatic cholesterol deposition in alcoholic fatty liver via hepatitis B core protein
por: Wang, Yaqi, et al.
Publicado: (2018)

Serum hepatitis B core antibody as a biomarker of hepatic inflammation in chronic hepatitis B patients with normal alanine aminotransferase
por: Zhou, Jiyuan, et al.
Publicado: (2017)

Risk of Reactivation of Hepatitis B in Hepatitis B Surface Antigen-Negative and Hepatitis B Core Antigen Antibody Positive Patients Receiving Biologic Therapy
por: Gök Sargın, Zeynep
Publicado: (2023)

1026. Hepatitis B Reactivation in Persons with HIV with Positive Hepatitis B Core Antibody after Switching to Antiretroviral Therapy without Hepatitis B Activity
por: Denyer, Rachel V, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gi24kcapjntpha7a5m7mkv1i6r